Resistance to the anti-proliferative activity of recombinant arginine deiminase in cell culture correlates with the endogenous enzyme, argininosuccinate synthetase

Arginine metabolism: nitric oxide and beyond

WU, G., & MORRIS, S. M. (1998) · Biochemical Journal · doi:10.1042/bj3360001 · Cited by 2,811 · see citing works

Use of ?-asparaginase in childhood ALL

Müller, H.-J. (1998) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(98)00015-8 · Cited by 458 · see citing works

Sustained Nitric Oxide Production in Macrophages Requires the Arginine Transporter CAT2

Nicholson, B., Manner, C. K., Kleeman, J. E., & MacLeod, C. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010030200 · Cited by 233 · see citing works

Coinduction of nitric oxide synthase and argininosuccinate synthetase in a murine macrophage cell line. Implications for regulation of nitric oxide production.

Nussler, A. K., Billiar, T. R., Liu, Z. Z., & Morris, S. M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42251-4 · Cited by 217 · see citing works

Single amino acid (arginine) deprivation: rapid and selective death of cultured transformed and malignant cells

Scott, L., Lamb, J., Smith, S. H., & Wheatley, D. N. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1353 · Cited by 178 · see citing works

Argininosuccinate synthetase mRNA and activity are induced by immunostimulants in vascular smooth muscle. Role in the regeneration or arginine for nitric oxide synthesis

Hattori, Y., Campbell, E. B., & Gross, S. S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36893-x · Cited by 147 · see citing works

Arginine deiminase inhibits proliferation of human leukemia cells more potently than asparaginase by inducing cell cycle arrest and apoptosis

Gong, H., Zölzer, F., Recklinghausen, G. V., Havers, W., & Schweigerer, L. (2000) · Leukemia · doi:10.1038/sj.leu.2401763 · Cited by 138 · see citing works

In vivo anti‐tumor activity of arginine deiminase purified from Mycoplasma arginini

Takaku, H., Takase, M., Abe, S., Hayashi, H., & Miyazaki, K. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910510213 · Cited by 123 · see citing works

Potent growth inhibition of human tumor cells in culture by arginine deiminase purified from a culture medium of a Mycoplasma-infected cell line.

Miyazaki, K., Takaku, H., Umeda, M., Fujita, T., Huang, W. D., Kimura, T., Yamashita, J., & Horio, T. (1990) · PubMed · Cited by 115 · see citing works

Caveolar Localization of Arginine Regeneration Enzymes, Argininosuccinate Synthase, and Lyase, with Endothelial Nitric Oxide Synthase

Flam, B. R., Hartmann, P. J., Harrell-Booth, M., Solomonson, L. P., & Eichler, D. C. (2001) · Nitric Oxide · doi:10.1006/niox.2001.0340 · Cited by 103 · see citing works

Anti‐tumor Activity of Arginine Deiminase from Mycoplasma arginini and Its Growth‐inhibitory Mechanism

Takaku, H., Matsumoto, M., Misawa, S., & Miyazaki, K. (1995) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1995.tb03094.x · Cited by 89 · see citing works

Arginine Deiminase Inhibits Cell Proliferation by Arresting Cell Cycle and Inducing Apoptosis

Gong, H., Zölzer, F., Recklinghausen, G. V., Rössler, J. K., Breit, S., Havers, W., Fotsis, T., & Schweigerer, L. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1004 · Cited by 76 · see citing works

Recombinant arginine deiminase as a potential anti-angiogenic agent

Beloussow, K., Wang, L., Wu, J., Ann, D. K., & Shen, W. (2002) · Cancer Letters · doi:10.1016/s0304-3835(01)00793-5 · Cited by 71 · see citing works

High-level expression of Mycoplasma arginine deiminase in Escherichia coli and its efficient renaturation as an anti-tumor enzyme

Misawa, S., Aoshima, M., Takaku, H., Matsumoto, M., & Hayashi, H. (1994) · Journal of Biotechnology · doi:10.1016/0168-1656(94)90050-7 · Cited by 69 · see citing works

Single Amino Acid (Arginine) Restriction: Growth and Death of Cultured HeLa and Human Diploid Fibroblasts

Wheatley, D. N., Scott, L., Lamb, J., & Smith, S. H. (2000) · Cellular Physiology and Biochemistry · doi:10.1159/000016333 · Cited by 64 · see citing works

[92] Isolation and determination of arginine and citrulline

Oginsky, E. L. (1957) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(57)03434-5 · Cited by 55 · see citing works

Isolation and characterization of argininosuccinate synthetase from human liver

O’Brien, W. E. (1979) · Biochemistry · doi:10.1021/bi00591a015 · Cited by 53 · see citing works

Targeting Metabolism for Cancer Therapy

Luengo, A., Gui, D. Y., & Vander Heiden, M. G. (2017) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.08.028 · Cited by 971 · see citing works

Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer

Delage, B., Fennell, D. A., Nicholson, L., McNeish, I., Lemoine, N. R., Crook, T., & Szlosarek, P. W. (2010) · International Journal of Cancer · doi:10.1002/ijc.25202 · Cited by 441 · see citing works

Pegylated Recombinant Human Arginase (rhArg-peg5,000mw) Inhibits the In vitro and In vivo Proliferation of Human Hepatocellular Carcinoma through Arginine Depletion

Cheng, P., Lam, T. L., Lam, W.-M., Tsui, S. M., Cheng, A. W. M., Lo, W. H., & Leung, Y. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1945 · Cited by 279 · see citing works

Emerging PEGylated drugs

Kang, J. S., DeLuca, P. P., & Lee, K. C. (2009) · Expert Opinion on Emerging Drugs · doi:10.1517/14728210902907847 · Cited by 252 · see citing works

Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: results from phase I/II studies

Izzo, F., Marra, P., Beneduce, G., Castello, G., Vallone, P., De Rosa, V., Cremona, F., Ensor, C. M., Holtsberg, F. W., Bomalaski, J. S., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.11.120 · Cited by 250 · see citing works

Arginine Deprivation as a Targeted Therapy for Cancer

Feun, L. G., You, M., Wu, C., Kuo, M. T., Wangpaichitr, M., Spector, S. A., & Savaraj, N. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784246199 · Cited by 235 · see citing works

Targeting arginine-dependent cancers with arginine-degrading enzymes: opportunities and challenges

Phillips, M. M., Sheaff, M. T., & Szlosarek, P. W. (2013) · Cancer Research and Treatment · doi:10.4143/crt.2013.45.4.251 · Cited by 229 · see citing works

In vivo Loss of Expression of Argininosuccinate Synthetase in Malignant Pleural Mesothelioma Is a Biomarker for Susceptibility to Arginine Depletion

Szlosarek, P. W., Klampatsa, A., Pallaska, A., Sheaff, M. T., Smith, P., Crook, T., Grimshaw, M. J., Steele, J. P. C., Rudd, R., Balkwill, F. R., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1101 · Cited by 181 · see citing works

Renal cell carcinoma does not express argininosuccinate synthetase and is highly sensitive to arginine deprivation<i>via</i>arginine deiminase

Yoon, C., Shim, Y., Kim, E., Lee, J., Won, N., Kim, J., Park, I., Yoon, D., & Min, B. (2007) · International Journal of Cancer · doi:10.1002/ijc.22322 · Cited by 165 · see citing works

Arginine Deprivation Inhibits the Warburg Effect and Upregulates Glutamine Anaplerosis and Serine Biosynthesis in ASS1-Deficient Cancers

Kremer, J. C., Prudner, B. C., Lange, S. E. S., Bean, G. R., Schultze, M., Brashears, C. B., Radyk, M. D., Redlich, N. J., Tzeng, S., Kami, K., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.077 · Cited by 160 · see citing works

Pancreatic cancer cell lines deficient in argininosuccinate synthetase are sensitive to arginine deprivation by arginine deiminase

Bowles, T. L., Kim, R., Galante, J., Parsons, C. M., Virudachalam, S., Kung, H., & Bold, R. J. (2008) · International Journal of Cancer · doi:10.1002/ijc.23723 · Cited by 153 · see citing works

Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma

Ott, P. A., Carvajal, R. D., Pandit-Taskar, N., Jungbluth, A. A., Hoffman, E. W., Wu, B.-W., Bomalaski, J. S., Venhaus, R., Pan, L., Old, L. J., et al. (2013) · Investigational New Drugs · doi:10.1007/s10637-012-9862-2 · Cited by 146 · see citing works

Reduced Argininosuccinate Synthetase Is a Predictive Biomarker for the Development of Pulmonary Metastasis in Patients with Osteosarcoma

Kobayashi, E., Masuda, M., Nakayama, R. T., Ichikawa, H., Satow, R., Shitashige, M., Honda, K., Yamaguchi, U., Shoji, A., Tochigi, N., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0774 · Cited by 120 · see citing works

Pegylated arginine deiminase: a novel anticancer enzyme agent

Feun, L. G., & Savaraj, N. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.7.815 · Cited by 118 · see citing works

Arginine deiminase PEG20 inhibits growth of small cell lung cancers lacking expression of argininosuccinate synthetase

Kelly, M. P., Jungbluth, A. A., Wu, B.-W., Bomalaski, J. S., Old, L. J., & Ritter, G. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.524 · Cited by 117 · see citing works

Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminase

Feun, L. G., Marini, A., Walker, G., Elgart, G., Moffat, F., Rodgers, S. E., Wu, C. J., You, M., Wangpaichitr, M., Kuo, M. T., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.106 · Cited by 113 · see citing works

Recombinant human arginase inhibits the in vitro and in vivo proliferation of human melanoma by inducing cell cycle arrest and apoptosis

Lam, A. T., Wong, G., Chow, H., Chong, H.-C., Chow, T. L., Kwok, S.-Y., Cheng, P. N.-M., Wheatley, D. N., Lo, W., & Leung, Y. (2010) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2010.00798.x · Cited by 99 · see citing works

Amino acid deprivation using enzymes as a targeted therapy for cancer and viral infections

Fernandes, H. S., Teixeira, C. S. S., Fernandes, P. A., Ramos, M. J., & Cerqueira, N. M. F. S. A. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2017.1254194 · Cited by 91 · see citing works

Microbial-based therapy of cancer: Current progress and future prospects

Bernardes, N., Seruca, R., Chakrabarty, A. M., & Fialho, A. M. (2010) · Bioengineered Bugs · doi:10.4161/bbug.1.3.10903 · Cited by 88 · see citing works

Sensitivity of Colorectal Cancer to Arginine Deprivation Therapy is Shaped by Differential Expression of Urea Cycle Enzymes

Alexandrou, C., Al-Aqbi, S. S., Higgins, J. A., Boyle, W., Karmokar, A., Andreadi, C., Luo, J., Moore, D. A., Viskaduraki, M., Blades, M., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-30591-7 · Cited by 86 · see citing works

Recombinant human arginase inhibits proliferation of human hepatocellular carcinoma by inducing cell cycle arrest

Lam, T. L., Wong, G., Chong, H.-C., Cheng, P. N.-M., Choi, S. C., Chow, T. L., Kwok, S.-Y., Poon, R. T. P., Wheatley, D. N., Lo, W., et al. (2009) · Cancer Letters · doi:10.1016/j.canlet.2008.11.031 · Cited by 87 · see citing works

Polyethyleneimine-Based Core-Shell Nanogels: A Promising siRNA Carrier for Argininosuccinate Synthetase mRNA Knockdown in HeLa Cells

Mimi, H., Ho, K. M., Siu, Y. S., Wu, A., & Li, P. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.10.035 · Cited by 79 · see citing works

Controlling cancer by restricting arginine availability–arginine-catabolizing enzymes as anticancer agents

Wheatley, D. N. (2004) · Anti-Cancer Drugs · doi:10.1097/00001813-200410000-00002 · Cited by 74 · see citing works

Arginine deprivation and metabolomics: Important aspects of intermediary metabolism in relation to the differential sensitivity of normal and tumour cells

Wheatley, D. N. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.04.002 · Cited by 62 · see citing works

Accessibility of endothelial and inducible nitric oxide synthase to the intracellular citrulline–arginine regeneration pathway

Shen, L., Beloussow, K., & Shen, W. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.09.003 · Cited by 60 · see citing works

Modulation of arginine metabolic pathways as the potential anti-tumor mechanism of recombinant arginine deiminase

Shen, L., Beloussow, K., & Shen, W. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.01.007 · Cited by 59 · see citing works

The arginine metabolism and its deprivation in cancer therapy

Feng, T., Xie, F., Lyu, Y., Yu, P., Chen, B., Yu, J., Zhang, G., To, K. F., Tsang, C. M., & Kang, W. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217680 · Cited by 52 · see citing works

Selective Intracellular Delivery of Recombinant Arginine Deiminase (ADI) Using pH-Sensitive Cell Penetrating Peptides To Overcome ADI Resistance in Hypoxic Breast Cancer Cells

Yeh, T.-H., Chen, Y.-R., Chen, S., Shen, W., Ann, D. K., Zaro, J. L., & Shen, L. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00706 · Cited by 53 · see citing works

Recombinant human arginase induced caspase-dependent apoptosis and autophagy in non-Hodgkin’s lymphoma cells

Zeng, X. L., Li, Y., Fan, J., Zhao, H., Xian, Z., Sun, Y., Wang, Z., Wang, S.-G., Zhang, G., & Ju, D. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.359 · Cited by 51 · see citing works

Arginase 2 is expressed by human lung cancer, but it neither induces immune suppression, nor affects disease progression

Rotondo, R., Mastracci, L., Piazza, T., Barisione, G., Fabbi, M., Cassanello, M., Costa, R., Morandi, B., Astigiano, S., Cesario, A., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23437 · Cited by 45 · see citing works

Arginine deprivation as a new treatment strategy for head and neck cancer

Huang, C., Tsai, S., Kuo, C., Chang, J. S.-M., Jin, Y., Chang, J., & Hsiao, J. (2012) · Oral Oncology · doi:10.1016/j.oraloncology.2012.06.004 · Cited by 41 · see citing works

Arginine deiminase enhances dexamethasone‐induced cytotoxicity in human T‐lymphoblastic leukemia CCRF‐CEM cells

Noh, E., Kang, S., Shin, Y., Choi, S., Kim, C., Park, I.-S., Wheatley, D. N., & Min, B. (2004) · International Journal of Cancer · doi:10.1002/ijc.20435 · Cited by 40 · see citing works

Hypoxia-induced nitric oxide production and tumour perfusion is inhibited by pegylated arginine deiminase (ADI-PEG20)

Burrows, N., Cane, G., Robson, M. P., Gaude, E., Howat, W., Szlosarek, P. W., Pedley, R. B., Frezza, C., Ashcroft, M. A., & Maxwell, P. H. (2016) · Scientific Reports · doi:10.1038/srep22950 · Cited by 37 · see citing works

Cytotoxicity of human recombinant arginase I (Co)-PEG5000 in the presence of supplemental L-citrulline is dependent on decreased argininosuccinate synthetase expression in human cells

Agrawal, V., Woo, J. H., Mauldin, J., Jo, C., Stone, E. M., Georgiou, G., & Frankel, A. E. (2011) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e32834ae42b · Cited by 34 · see citing works

The relationship of arginine deprivation, argininosuccinate synthetase and cell death in melanoma.

Savaraj, N., Wu, C., Kuo, M. T., You, M., Wangpaichitr, M., Robles, C., Spector, S. A., & Feun, L. G. (2007) · Europe PMC (PubMed Central) · Cited by 32 · see citing works

Recombinant arginine deiminase as a differential modulator of inducible (iNOS) and endothelial (eNOS) nitric oxide synthetase activity in cultured endothelial cells

Shen, L., Lin, W., Beloussow, K., Hosoya, K., Terasaki, T., Ann, D. K., & Shen, W. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00555-0 · Cited by 32 · see citing works

Arginine depriving enzymes: applications as emerging therapeutics in cancer treatment

Kumari, N., & Bansal, S. (2021) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-021-04335-w · Cited by 30 · see citing works

The Relationship of Arginine Deprivation, Argininosuccinate Synthetase and Cell Death in Melanoma

Savaraj, N., Wu, C., Kuo, M. T., You, M., Wangpaichitr, M., Robles, C., Spector, S. A., & Feun, L. G. (2007) · Drug Target Insights · doi:10.1177/117739280700200016 · Cited by 30 · see citing works

Recombinant arginine deiminase reduces inducible nitric oxide synthase iNOS‐mediated neurotoxicity in a coculture of neurons and microglia

Yu, H., Wu, F. L., Lin, S., & Shen, L. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21740 · Cited by 29 · see citing works

[HuArgI (co)-PEG5000]-induced arginine deprivation leads to autophagy dependent cell death in pancreatic cancer cells

Khalil, N., & Abi‐Habib, R. J. (2019) · Investigational New Drugs · doi:10.1007/s10637-019-00883-4 · Cited by 27 · see citing works

Anti-tumor activity of arginine deiminase via arginine deprivation in retinoblastoma

Kim, J. H., Kim, J. H., Yu, Y. S., Kim, D. W., Min, B.-H., & Kim, K.-W. (2007) · Oncology Reports · doi:10.3892/or.18.6.1373 · Cited by 26 · see citing works

Treating liver cancer through arginine depletion

Prasad, Y. R., Anakha, J., & Pande, A. H. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.103940 · Cited by 27 · see citing works

An Engineered Arginase FC Protein Inhibits Tumor GrowthIn VitroandIn Vivo

Li, L., Wang, Y., Chen, J., Cheng, B., Hu, J., Zhou, Y., Gao, X., Gao, L., Mei, X., Sun, M., et al. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/423129 · Cited by 24 · see citing works

Insight into the interplay between mitochondria-regulated cell death and energetic metabolism in osteosarcoma

Lai, H.-T., Naumova, N., Marchais, A., Gaspar, N., Geoerger, B., & Brenner, C. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.948097 · Cited by 23 · see citing works

Arginine Is a Novel Drug Target for Arginine Decarboxylase in Human Colorectal Cancer Cells

Wei, X., Chow, H., Chong, H.-C., Leung, S.-L., Ho, M.-K., Lee, L. M.-Y., & Leung, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813741 · Cited by 18 · see citing works

Arginine Deiminase Enhances MCF-7 Cell Radiosensitivity by Inducing Changes in the Expression of Cell Cycle-related Proteins

Park, H., Lee, J., Shim, Y.-J., Shin, Y., Jeong, S.-Y., Oh, J., Park, G. H., Lee, K.-H., & Min, B.-H. (2008) · Molecules and Cells · doi:10.1016/s1016-8478(23)17586-8 · Cited by 17 · see citing works

Intracellular Delivery of Recombinant Arginine Deiminase (rADI) by Heparin-Binding Hemagglutinin Adhesion Peptide Restores Sensitivity in rADI-Resistant Cancer Cells

Wu, F. L., Yeh, T.-H., Chen, Y.-L., Chiu, Y.-C., Cheng, J.-C., Wei, M., & Shen, L. (2014) · Molecular Pharmaceutics · doi:10.1021/mp5001372 · Cited by 16 · see citing works

Arginine Deiminase Induces Immunogenic Cell Death and Is Enhanced by N-acetylcysteine in Murine MC38 Colorectal Cancer Cells and MDA-MB-231 Human Breast Cancer Cells In Vitro

Huang, Z., & Hu, H. (2021) · Molecules · doi:10.3390/molecules26020511 · Cited by 16 · see citing works

Effect of dietary l-arginine of broiler breeder hens on embryonic development, apparent metabolism, and immunity of offspring

Li, F., Ning, H., Duan, X., Chen, Z., & Xu, L. (2020) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2020.106537 · Cited by 14 · see citing works

Argininosuccinate synthetase (ASS) deficiency in high-grade pulmonary neuroendocrine carcinoma: an opportunity for personalized targeted therapy

Walts, A. E., Bomalaski, J. S., Ines, D., & Oršulić, S. (2014) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1904-z · Cited by 12 · see citing works

Cell Penetrating Peptide: Sequence-Based Computational Prediction for Intercellular Delivery of Arginine Deiminase

Zarei, M., Rahbar, M. R., Negahdaripour, M., Morowvat, M. H., Nezafat, N., & Ghasemi, Y. (2019) · Current Proteomics · doi:10.2174/1570164616666190701120351 · Cited by 11 · see citing works

RNA interference of argininosuccinate synthetase restores sensitivity to recombinant arginine deiminase (rADI) in resistant cancer cells

Wu, F. L., Liang, Y.-F., Chang, Y.-C., Yo, H.-H., Wei, M., & Shen, L. (2011) · Journal of Biomedical Science · doi:10.1186/1423-0127-18-25 · Cited by 9 · see citing works

Dependence of leukemic cell proliferation and survival on H2O2 and l-arginine

Brown, R. D., Burke, G. A. A., & Brown, G. C. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.02.001 · Cited by 8 · see citing works

Cancer therapies based on enzymatic amino acid depletion

Teixeira, C. S. S., Fernandes, H. S., Fernandes, P. A., Ramos, M. J., & Cerqueira, N. M. F. S. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-46144-3.00024-6 · Cited by 6 · see citing works

Analysis of Arginine Metabolism Using LC-MS and Isotopic Labeling

Seim, G. L., Britt, E. C., & Fan, J. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9236-2_13 · Cited by 4 · see citing works

Inhibition of LPS-induced nitric oxide production by transduced Tat-arginine deiminase fusion protein in Raw 264.7 cells

Lee, M.-J., Kim, D. W., Lee, Y.-P., Jeong, H.-J., Kang, H.-W., Shin, M.-J., Sohn, E. J., Kim, M. J., Jang, S.-H., Kang, T., et al. (2009) · BMB Reports · doi:10.5483/bmbrep.2009.42.5.286 · Cited by 3 · see citing works

Increased L -arginine transport via system b0,+ in human proximal tubular cells exposed to albumin

Ashman, N., Brunini, T. M. C., Mann, G. E., Ribeiro, A. C. M., & Yaqoob, M. M. (2006) · Clinical Science · doi:10.1042/cs20060158 · Cited by 3 · see citing works

The Relationship of Arginine Deprivation, Argininosuccinate Synthetase and Cell Death in Melanoma

Savaraj, N., Wu, C., Kuo, M. T., You, M., Wangpaichitr, M., Robles, C., Spector, S. A., & Feun, L. G. (2007) · Drug Target Insights · doi:10.33393/dti.2007.1314 · Cited by 2 · see citing works

Energetics of whole genome doubling and genomic instability

Beck, R. J., Tagal, V., Amin, S. B., Bakhoum, S. F., Maley, C. C., Verhaak, R. G. W., Gomes, A. P., & Andor, N. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217878 · Cited by 1 · see citing works

Arginine Deiminase and Cancer Therapy

Feun, L. G., Kuo, M. T., You, M., Wu, C. J., Wangpaichitr, M., & Savaraj, N. (2010) · doi:10.1002/9780470626528.ch9 · Cited by 1 · see citing works

Amphiphilic Core–Shell Nanoparticles Containing Hairy Polyethyleneimine Shells as Effective Nanocarriers for Gene and siRNA Delivery

Li, P., Siu, Y. S., Ho, K. M., & Li, W. (2013) · Regenerative medicine, artificial cells and nanomedicine · doi:10.1142/9789814472869_0018

Targeting arginine auxotrophy in pancreatic cancer cells using human recombinant arginase I-induced arginine deprivation

Khalil, N. (2017) · doi:10.26756/th.2017.5

Data from Reduced Argininosuccinate Synthetase Is a Predictive Biomarker for the Development of Pulmonary Metastasis in Patients with Osteosarcoma

Kobayashi, E., Masuda, M., Nakayama, R. T., Ichikawa, H., Satow, R., Shitashige, M., Honda, K., Yamaguchi, U., Shoji, A., Tochigi, N., et al. (2023) · doi:10.1158/1535-7163.c.6531447

Data from Reduced Argininosuccinate Synthetase Is a Predictive Biomarker for the Development of Pulmonary Metastasis in Patients with Osteosarcoma

Kobayashi, E., Masuda, M., Nakayama, R. T., Ichikawa, H., Satow, R., Shitashige, M., Honda, K., Yamaguchi, U., Shoji, A., Tochigi, N., et al. (2023) · doi:10.1158/1535-7163.c.6531447.v1

Arginine deprivation induces ROS dependent autophagic cell death in human acute myeloid leukemia cells

Taki, F., Farhat, M. H., Atat, O. E., Al-Samman, S., Assaf, N., & Abi‐Habib, R. J. (2026) · Human Cell · doi:10.1007/s13577-026-01370-8

Arginine deprivation induces prolonged autophagy activation and ROS-dependent cell death in glioblastoma multiforme

Abdelkhalek, M., El-Jawhari, Y., Shaheen, M., Saad, R., Sarieddine, M., El-Husseini, N., El‐Sibai, M., & Abi‐Habib, R. J. (2026) · CNS Oncology · doi:10.1080/20450907.2026.2666026

RNA interference of argininosuccinate synthetase restores sensitivity to recombinant arginine deiminase (rADI) in resistant cancer cells

Wu, F. L., Liang, Y.-F., Chang, Y.-C., Yo, H.-H., Wei, M., & Shen, L. (2011) · Journal of Biomedical Science · doi:10.1186/1423-0127-18-25 · Cited by 9 · see citing works

Modulation of arginine metabolic pathways as the potential anti-tumor mechanism of recombinant arginine deiminase

Shen, L., Beloussow, K., & Shen, W. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.01.007 · Cited by 59 · see citing works

精胺琥珀合成(酉每)的短髮夾核醣核酸(shRNA)於對基因合成精胺酸去亞胺(酉每)具有抗性之癌細胞株的效果

Liang, Y.-F., & 梁玉芬 (2009) · doi:10.6342/ntu.2009.03052

Renal cell carcinoma does not express argininosuccinate synthetase and is highly sensitive to arginine deprivation<i>via</i>arginine deiminase

Yoon, C., Shim, Y., Kim, E., Lee, J., Won, N., Kim, J., Park, I., Yoon, D., & Min, B. (2007) · International Journal of Cancer · doi:10.1002/ijc.22322 · Cited by 165 · see citing works

Open Access

(2013)